MELE Stock Analysis: Melexis | BR
Semiconductors | BR, Belgium | Market Cap: 2.786m EUR | 12M Return: 1.9% | BE0165385973 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.76M
EPS Trend: -95.5%
Qual. Beats: 0
Rev. Trend: -85.2%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Melexis NV (MELE) is a Belgian semiconductor company that designs, develops, and markets advanced integrated semiconductor devices, primarily serving the automotive industry across Europe, the Middle East, Africa, Asia Pacific, and the Americas. Founded in 1988 and headquartered in Ieper, Belgium, the company offers a broad portfolio that includes a wide range of sensor ICs (current, position, speed, pressure, temperature, tire monitoring, and time-of-flight), embedded motor and lighting driver ICs, and transceiver ICs supporting protocols such as LIN, CAN, and RFID. As a mid-cap firm in the Information Technology sector, Melexis generates most of its revenue from automotive-grade analog and mixed-signal semiconductors, a segment that has seen sustained growth driven by increasing electronic content per vehicle, particularly in electrified and advanced driver-assistance (ADAS) applications.
- Automotive sensor demand recovers as global car production normalizes
- Electric vehicle adoption lifts semiconductor content per vehicle
- Inventory destocking in automotive chips pressures gross margins
| Net Income: 104.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.24 > 0.02 and ΔFCF/TA 14.52 > 1.0 |
| NWC/Revenue: 53.68% < 20% (prev 53.48%; Δ 0.20% < -1%) |
| CFO/TA 0.29 > 3% & CFO 239.4m > Net Income 104.0m |
| Net Debt (271.5m) to EBITDA (193.6m): 1.40 < 3 |
| Current Ratio: 5.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (40.5m) vs 12m ago 0.42% < -2% |
| Gross Margin: 39.38% > 18% (prev 40.24%; Δ -0.86% > 0.5%) |
| Asset Turnover: 96.51% > 50% (prev 92.13%; Δ 4.37% > 0%) |
| Interest Coverage Ratio: 10.50 > 6 (EBIT TTM 141.1m / Interest Expense TTM 13.4m) |
| A: 0.55 (Total Current Assets 549.2m - Total Current Liabilities 93.5m) / Total Assets 831.2m |
| B: 0.60 (Retained Earnings 499.0m / Total Assets 831.2m) |
| C: 0.16 (EBIT TTM 141.1m / Avg Total Assets 879.7m) |
| D: 1.10 (Book Value of Equity 435.7m / Total Liabilities 395.5m) |
| Altman-Z'' = 7.79 = AAA |
| DSRI: 0.71 (Receivables 139.1m/197.7m, Revenue 848.9m/855.1m) |
| GMI: 1.02 (GM 40.24% / 39.38%) |
| AQI: 0.56 (AQ_t 0.10 / AQ_t-1 0.17) |
| SGI: 0.99 (Revenue 848.9m / 855.1m) |
| TATA: -0.16 (NI 104.0m - CFO 239.4m) / TA 831.2m) |
| Beneish M = -3.53 (Cap -4..+1) = AAA |
As of August 20, 2026, the stock is trading at EUR 65.80 with a total of 36,174 shares traded. Over the past week, the price has changed by -9.24%, over one month by -4.71%, over three months by -11.62% and over the past year by +1.88%.
Current recommended Stop Loss: 62.50 (which is 5% or 1.3 ATR below the current price).
Melexis has no consensus analysts rating.
P/E Trailing = 27.5292
P/E Forward = 22.2717
P/S = 3.2817
P/B = 6.4894
P/EG = 2.2764
Revenue TTM = 848.9m EUR
EBIT TTM = 141.1m EUR
EBITDA TTM = 193.6m EUR
Long Term Debt = 290.1m EUR (from longTermDebt, last quarter)
Short Term Debt = 5.09m EUR (from shortTermDebt, last quarter)
Debt = 308.9m EUR (from shortLongTermDebtTotal, last quarter) + Leases 7.85m
Net Debt = 271.5m EUR (calculated: Debt 308.9m - CCE 37.3m)
Enterprise Value = 3.06b EUR (2.79b + Debt 308.9m - CCE 37.3m)
Interest Coverage Ratio = 10.50 (Ebit TTM 141.1m / Interest Expense TTM 13.4m)
EV/FCF = 15.02x (Enterprise Value 3.06b / FCF TTM 203.5m)
FCF Yield = 6.66% (FCF TTM 203.5m / Enterprise Value 3.06b)
FCF Margin = 23.97% (FCF TTM 203.5m / Revenue TTM 848.9m)
Net Margin = 12.25% (Net Income TTM 104.0m / Revenue TTM 848.9m)
Gross Margin = 39.38% ((Revenue TTM 848.9m - Cost of Revenue TTM 514.7m) / Revenue TTM)
Gross Margin QoQ = 40.51% (prev 39.89%)
Tobins Q-Ratio = 3.68 (Enterprise Value 3.06b / Total Assets 831.2m)
Interest Expense / Debt = 4.35% (Interest Expense 13.4m / Debt 308.9m)
Taxrate = 18.54% (23.7m / 127.6m)
NOPAT = 114.9m (EBIT 141.1m * (1 - 18.54%))
Current Ratio = 5.87 (Total Current Assets 549.2m / Total Current Liabilities 93.5m)
Debt / Equity = 0.71 (Debt 308.9m / totalStockholderEquity, last quarter 435.7m)
Debt / EBITDA = 1.40 (Net Debt 271.5m / EBITDA 193.6m)
Debt / FCF = 1.33 (Net Debt 271.5m / FCF TTM 203.5m)
Total Stockholder Equity = 488.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.82% (Net Income 104.0m / Total Assets 831.2m)
RoE = 21.28% (Net Income TTM 104.0m / Total Stockholder Equity 488.5m)
RoCE = 18.12% (EBIT 141.1m / Capital Employed (Equity 488.5m + L.T.Debt 290.1m))
RoIC = 16.29% (NOPAT 114.9m / Invested Capital 705.4m)
WACC = 9.26% (E(2.79b)/V(3.09b) * Re(9.89%) + D(308.9m)/V(3.09b) * Rd(4.35%) * (1-Tc(0.19)))
Discount Rate = 9.89% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -42.01 | Cagr: 0.08%
[DCF] Terminal Value 75.09% ; FCFF base≈159.1m ; Y1≈182.4m ; Y5≈268.4m
[DCF] Fair Price = 81.57 (EV 3.48b - Net Debt 271.5m = Equity 3.21b / Shares 39.4m; r=9.26% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -95.45 | EPS CAGR: -27.18% | SUE: 0.18 | # QB: 0
Revenue Correlation: -85.22 | Revenue CAGR: -6.42% | SUE: 1.45 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.86 | Chg30d=+1.66% | Revisions=+17% | Analysts=4
EPS current Year (2026-12-31): EPS=3.05 | Chg30d=+1.22% | Revisions=+22% | GrowthEPS=+9.9% | GrowthRev=+3.4%
EPS next Year (2027-12-31): EPS=3.85 | Chg30d=-0.85% | Revisions=+0% | GrowthEPS=+26.2% | GrowthRev=+9.6%
[Analyst] Revisions Ratio: +15% (up=10, down=7)